(Q48445988)

11 February 2018

title

The cuprizone model: regional heterogeneity of pathology (English)

1 reference

11 February 2018

0 references

1 reference

1 reference

3

Kjell-Morten Myhr

1 reference

11 February 2018

2

Øivind Torkildsen

1 reference

11 February 2018

Stig Wergeland

series ordinal

1

object named as

Stig Wergeland

1 reference

11 February 2018

Sverre J Mörk

series ordinal

4

object named as

Sverre Jarl Mørk

1 reference

11 February 2018

author name string

Lars Bø

series ordinal

5

1 reference

11 February 2018

publication date

24 February 2012

1 reference

11 February 2018

Acta Pathologica et Microbiologica Scandinavica

published in

1 reference

11 February 2018

volume

120

1 reference

11 February 2018

issue

8

1 reference

11 February 2018

page(s)

648-657

1 reference

11 February 2018

Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Evidence for a “dying‐back” gliopathy in demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Subpial demyelination in the cerebral cortex of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

The blood-brain barrier in cortical multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Multiple sclerosis: distribution of inflammatory cells in newly forming lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Mitochondrial defects in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Regional differences between grey and white matter in cuprizone induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

The cuprizone model for demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Cuprizone neurotoxicity, copper deficiency and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

In toxic demyelination oligodendroglial cell death occurs early and is FAS independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Cuprizone and piperonyl butoxide, proposed inhibitors of T-cell function, attenuate experimental allergic encephalomyelitis in SJL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Copper deficiency reversibly impairs DNA synthesis in activated T lymphocytes by limiting interleukin 2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

Homogeneity of active demyelinating lesions in established multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2012.02882.X

10.1111/J.1600-0463.2012.02882.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018